Taking semaglutide once weekly may lower the chances of kidney disease, says study

FHS
May 28, 2024
10:12 am

The effects of semaglutide (administered once weekly) on the outcomes of kidney disease.

Go green in Ghana ‘forestmaker’ Tonyrinaudo with world vision on site at Knauer

Berlin-based manufacturer of high-tech laboratory measuring devices KNAUER hosted a sustainability event with 120 guests at its premises on May 29, 2024.

June 4, 2024

MindMed Reports Second Quarter 2024 Financial Results and Business Updates | Psychedelic Invest

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced

August 13, 2024

IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer

In patients with head and neck cancer, a strategy to reduce the radiation dose to dysphagia-and aspiration-related structures improved swallowing and other functional outcomes compared

July 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.